Cardiomyopathy Caused by a Pheochromocytoma Crisis in a 66-year-old Woman
Overview
Overview
Authors
Affiliations
Affiliations
Soon will be listed here.
References
1.
Eisenhofer G, Prejbisz A, Peitzsch M, Pamporaki C, Masjkur J, Rogowski-Lehmann N
. Biochemical Diagnosis of Chromaffin Cell Tumors in Patients at High and Low Risk of Disease: Plasma versus Urinary Free or Deconjugated -Methylated Catecholamine Metabolites. Clin Chem. 2018; 64(11):1646-1656.
DOI: 10.1373/clinchem.2018.291369.
View
2.
Reisch N, Peczkowska M, Januszewicz A, Neumann H
. Pheochromocytoma: presentation, diagnosis and treatment. J Hypertens. 2006; 24(12):2331-9.
DOI: 10.1097/01.hjh.0000251887.01885.54.
View
3.
Buitenwerf E, Osinga T, Timmers H, Lenders J, Feelders R, Eekhoff E
. Efficacy of α-Blockers on Hemodynamic Control during Pheochromocytoma Resection: A Randomized Controlled Trial. J Clin Endocrinol Metab. 2019; 105(7).
PMC: 7261201.
DOI: 10.1210/clinem/dgz188.
View
4.
Bravo E, Tagle R
. Pheochromocytoma: state-of-the-art and future prospects. Endocr Rev. 2003; 24(4):539-53.
DOI: 10.1210/er.2002-0013.
View
5.
Lenders J, Duh Q, Eisenhofer G, Gimenez-Roqueplo A, Grebe S, Murad M
. Pheochromocytoma and paraganglioma: an endocrine society clinical practice guideline. J Clin Endocrinol Metab. 2014; 99(6):1915-42.
DOI: 10.1210/jc.2014-1498.
View